Previous Close | 71.99 |
Open | 71.99 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 72.40 - 72.40 |
52 Week Range | 72.40 - 72.40 |
Volume | |
Avg. Volume | N/A |
Market Cap | 17.761M |
Beta (5Y Monthly) | 1.31 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.87 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The Danish Business Authority has conducted a compliance review of NNIT A/S’ annual reports as stated in company announcement 12/2022. Following dialogue with NNIT, the Danish Business Authority has made a final decision affirming that the earn out payment related to the acquisition of Excellis Health Solutions should not be included in capitalized acquisition costs and goodwill, but instead expensed as remuneration as the earn out is in part subject to the selling shareholders’ continued employ
With reference to company announcement 16/2022 published on December 8, 2022, NNIT hereby announces an updated financial calendar for 2023: March 3, 2023 Deadline for shareholder proposals for the Annual General MeetingPreviously January 31, 2023 March 23, 2023 Annual report 2022Previously February 1, 2023 April 17, 2023 Annual General MeetingPreviously March 15, 2023 May 5, 2023 Interim report for the first three months of 2023 August 10, 2023 Interim report for the first six months of 2023 Nov
The divestment of NNIT’s infrastructure operations to funds managed by Agilitas Private Equity LLP announced on June 22, 2022 is progressing well, and is now expected to close in Q1, 2023, against the initial expectation of closing the transaction six months from announcement, cf. company announcement 9/2022. The transaction requires consent of customers of the infrastructure operation. Most customers have by now rendered their consent, however the updated timeline reflects a few customers’ inte